

Episode 101: Colorectal Cancer Series, Pt. 3 - Adjuvant Therapy in Stage II Colon Cancer and ctDNA
May 1, 2024
Delve into the intricacies of stage II colon adenocarcinoma, where lack of nodal involvement raises critical treatment questions. Explore the potential benefits of adjuvant chemotherapy and the impact of microsatellite instability testing. Circulating tumor DNA (ctDNA) emerges as a fascinating tool for assessing therapy effectiveness. Plus, learn about the promising role of immunotherapy in certain colon cancer types. Personal anecdotes pepper the discussion, making complex topics more engaging!
Chapters
Transcript
Episode notes
1 2 3 4 5
Intro
00:00 • 2min
Navigating Stage II Colon Cancer Treatment
01:46 • 15min
Evaluating Adjuvant Therapy Benefits in Stage II Colon Cancer
16:57 • 4min
Navigating Chemotherapy Decisions in Stage II Colon Cancer
20:28 • 9min
Exploring Immunotherapy for Stage II and III Colon Cancer
29:10 • 5min